Results
Aurobindo Pharma Q2 Net Profit Up 32.5% YoY
Aurobindo Pharma reported Q2FY27 consolidated revenue of ₹10,263 Cr, up 23.9% YoY, with net profit of ₹1,124 Cr.
US revenue grew 25% YoY to ₹4,555 Cr; Europe revenue increased 27% YoY to ₹3,161 Cr.
Co
